Samsung Bioepis has changed its CEO for the first time since its launch. Kyung-ah Kim (56), Executive Vice President and Development Division Leader, has been appointed as CEO. This is the first female CEO appointed in the Samsung Group. Hansung Ko, who has served as CEO for 12 years since the launch of Samsung Bioepis, will take over as head of Samsung Future Business Division.

Samsung Bioepis today announced the promotion of Kyung-Ah Kim to the position of President and CEO. Born in 1968, Kim completed her bachelor's and master's degrees in pharmacy at Seoul National University. She then earned a doctorate in toxicology from Johns Hopkins University in the United States.

Kim is